Biomind Labs Inc. (BMND.NE) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
Biomind Labs Inc.

BRIEF

published on 11/21/2024 at 00:30, 10 hours 4 minutes ago

Biomind Labs Sees Opportunity in U.S. Policy Shift for Psychedelic Therapies

FDA Approval Psychedelic Therapies Neurological Disorders BMND08 Drug U.S. Policy Shift
PRESS RELEASE

published on 11/21/2024 at 00:25, 10 hours 9 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Biomind Labs Inc., a leading biotech company, optimistic about U.S. government's stance on psychedelic industry. Company's BMND08 shows promising results in Phase II trial for neuropsychiatric disorders

FDA Neuropsychiatric Disorders Biomind Labs Inc. BMND08 Psychedelic Industry
BRIEF

published on 07/18/2024 at 14:35, 4 months 2 days ago

Biomind Labs Advances New Obesity Treatment with BMND06 Candidate Targeting Neurological Pathways

Obesity Treatment Clinical Trial Biomind Labs BMND06 Anti-inflammatory
PRESS RELEASE

published on 07/18/2024 at 14:30, 4 months 2 days ago

Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways
Biomind Labs announced the decision to advance a Phase II clinical trial for BMND06, a novel compound with potential anti-inflammatory properties for treating obesity and neurological disorders

Phase II Trial Obesity Biomind Labs BMND06 Anti-inflammatory

Accesswire

Published on 11/21/2024 at 10:03, 31 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 34 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 34 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 59 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 9 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 29 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 32 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 34 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 34 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 33 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 36 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 14 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 49 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 49 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE